T cell activation requires at least two distinct signals, including si
gnaling via the Ag-specific TCR and a costimulatory pathway, The best
characterized costimulatory pathway involves the CD28 molecule, which
is expressed constitutively on T cells and binds the family of B7 coun
ter-receptors on APCs. Inhibition of this costimulatory pathway preven
ts T cell activation and can lead to long-term T cell unresponsiveness
or anergy, In contrast, CTLA4, which is homologous to CD28, has been
shown to be a negative regulator of T cell activation, The CTLA4 molec
ule is not expressed on resting T cells, but is induced after the init
ial steps of T cell activation, To address the regulation of CTLA4 exp
ression, we have analyzed CTLA4 at the level of cell surface expressio
n, mRNA, rate of transcription, and rate of decay of message, Nuclear
runoff results show an increase in the rate of transcription following
T cell activation, Our analyses of non-T cells, including B cells, ma
stocytoma, and fibroblasts, by Northern blot analysis detect only T ce
ll expression of CTLA4, Reporter gene analysis indicates that 335 bp o
f upstream CTLA4 sequence are sufficient to control inducibility, We h
ave identified important regulatory regions that control inducible and
cell-specific CTLA4 expression, These results also suggest that both
positive and negative response elements modulate the transcriptional r
egulation of CTLA4 gene expression, Understanding the regulation of CT
LA4 should provide insight into the regulation of T cell activation at
the molecular level.